SMTL ID : 6ob7.1

Human equilibrative nucleoside transporter-1, dilazep bound

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

18 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.1: 8 residues within 4Å: Chain A: S.259, V.260, F.263, S.264, F.267, P.331, V.334, L.335 Ligand excluded by PLIP OLC.2: 12 residues within 4Å: Chain A: Y.12, K.13, A.14, W.16, L.17, F.20, L.183, F.186, F.187, W.311 Ligands: OLC.3, OLC.17 Ligand excluded by PLIP OLC.3: 12 residues within 4Å: Chain A: K.13, W.16, S.172, F.186, I.308, W.311, L.312, S.315, L.316, A.318, V.319 Ligands: OLC.2 Ligand excluded by PLIP OLC.4: 10 residues within 4Å: Chain A: I.193, A.197, T.292, R.295, Y.296, V.300, L.304 Ligands: OLC.8, OLC.9, OLC.10 Ligand excluded by PLIP OLC.5: 4 residues within 4Å: Chain A: I.287, H.361, A.363 Ligands: OLC.6 Ligand excluded by PLIP OLC.6: 6 residues within 4Å: Chain A: H.361, A.363, W.364, F.367 Ligands: OLC.5, OLC.13 Ligand excluded by PLIP OLC.7: 12 residues within 4Å: Chain A: N.83, T.86, L.87, M.90, L.91, L.94, L.409, A.412, L.413, A.415, V.416, F.419 Ligand excluded by PLIP OLC.8: 12 residues within 4Å: Chain A: I.287, T.292, W.293, Y.296, F.297, V.300, S.301, D.362, I.366 Ligands: OLC.4, OLC.9, OLC.10 Ligand excluded by PLIP OLC.9: 3 residues within 4Å: Chain A: W.293 Ligands: OLC.4, OLC.8 Ligand excluded by PLIP OLC.10: 9 residues within 4Å: Chain A: V.300, S.301, L.304, T.305, I.308, F.309, I.366 Ligands: OLC.4, OLC.8 Ligand excluded by PLIP OLC.11: 10 residues within 4Å: Chain A: F.320, W.322, L.333, F.340, A.371, F.374, S.375, Y.378, L.379 Ligands: OLC.12 Ligand excluded by PLIP OLC.12: 5 residues within 4Å: Chain A: F.309, L.316, F.320, F.374 Ligands: OLC.11 Ligand excluded by PLIP OLC.13: 5 residues within 4Å: Chain A: V.358, F.359, W.364 Ligands: OLC.6, OLC.14 Ligand excluded by PLIP OLC.14: 3 residues within 4Å: Chain A: V.357, V.358 Ligands: OLC.13 Ligand excluded by PLIP OLC.15: 6 residues within 4Å: Chain A: V.131, K.132, S.203, E.204, F.207 Ligands: OLC.18 Ligand excluded by PLIP OLC.16: 8 residues within 4Å: Chain A: V.84, C.88, F.141, V.142, M.145, I.146, V.149, L.150 Ligand excluded by PLIP OLC.17: 13 residues within 4Å: Chain A: F.20, M.21, L.24, L.28, F.32, L.183, F.187, V.190, A.191, T.212, V.216, L.219 Ligands: OLC.2 Ligand excluded by PLIP OLC.18: 7 residues within 4Å: Chain A: E.204, F.207, G.208, I.211, T.212, A.215 Ligands: OLC.15 Ligand excluded by PLIP

1 x 8DZ: (1,4-diazepane-1,4-diyl)di(propane-3,1-diyl) bis(3,4,5-trimethoxybenzoate)(Non-covalent)

8DZ.19: 32 residues within 4Å: Chain A: L.27, W.30, N.31, M.34, T.35, T.37, N.82, M.85, T.86, A.89, M.90, L.93, N.152, G.155, Q.159, F.163, Q.181, G.185, A.188, S.189, M.192, F.269, I.273, F.276, P.277, F.303, N.307, R.314, L.407, C.408, L.411, A.415 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:M.34, A:T.35, A:F.303, A:L.411 Hydrogen bonds: A:W.30, A:Q.159, A:N.307 Water bridges: A:T.86, A:R.314

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wright, N.J. et al., Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat.Struct.Mol.Biol. (2019)

Release Date

2019-07-03

Peptides

Equilibrative nucleoside transporter 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Equilibrative nucleoside transporter 1

Related Entries With Identical Sequence